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Summary 
 
The practice of colonoscopy has changed considerably over the last decade. 
The growth of image enhanced endoscopy (IEE) have altered our concepts of 
how we perform colonoscopy. This article examines the evidence base behind 
these techniques and looks at where future research needs to be directed. 
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Expert commentary 
Paradigms in our understanding of how colonoscopy should be performed are 
shifting. Image enhanced endoscopy using both dye based chromoendoscopy 
and electronic imaging are providing us with methods of improving lesion 
detection and characterization beyond what we previously thought possible. 
Traditional views that the neoplastic potential of a lesion can only be 
determined by the pathologist are being challenged, and it is likely that the era 
of protocol guided mapping biopsies for surveillance of conditions such as 
ulcerative colitis are nearing an end. However, these technologies are not 
without limitations, and although they are all trying to achieve similar goals 
there are significant differences between them. Perhaps the biggest challenge 
that we now face will be to understand both how to train in these techniques 
effectively, and how to translate the large body of published research into 
routine clinical practice.  
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Five year view 
 
There will be a growth in the publication of guidelines from the World 
endoscopy societies setting standards for the use of image enhanced 
endoscopy in place of conventional approaches of mapping biopsies and 
histological examination. Training tools will emerge to enable structured 
training programmes to be developed, as will strategies for auditing success 
in application of these techniques to clinical practice.  Initially the techniques 
will be adopted by experts in tertiary referral centres, but dissemination to the 
wider community will occur as the practical difficulties of adoption of these 
approaches are solved.  
 
Key issues 
 Indigo carmine or methylene blue chromoendoscopy increases 
adenoma detection during routine colonoscopy 
 Indigo carmine or methylene blue Chromoendoscopy is the method of 
choice for the surveillance of patients with ulcerative colitis 
 Indigo carmine or methylene blue Chromoendoscopy is an effective 
tool for in-vivo histology prediction of colonic polyps 
 NBI and FICE have no role in polyp detection in a surveillance 
population. The position with i-scan is less clear. There is very little 
evidence in a high risk population, with a small selection of studies on 
NBI and i-scan suggesting they may be of some benefit in increasing 
the polyp detection rate 
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 There is a lack of evidence to recommend NBI, FICE or i-scan for 
surveillance of ulcerative colitis 
 There is good evidence for the use of NBI, FICE and i-scan for the in-
vivo histology prediction of colonic polyps 
 The adoption of a ‘resect and discard’ policy for colonic polyps may 
well be a very cost effective measure with minimal clinical 
consequences in expert hands 
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Introduction 
 
There have been considerable advances in the endoscopic examination and 
treatment of colonic neoplasia with the development of techniques for 
performing image enhanced endoscopy (IEE), including chromoendoscopy 
and electronic imaging. It is important to understand what can and cannot be 
achieved with these emerging technologies. This article reviews the evidence 
behind these new endoscopic enhancement techniques, and discusses where 
this field is likely to be moving in the future 
 
Background 
 
A key role of colonoscopy is lesion detection and characterization.  Colorectal 
cancer accounts for an estimated 550,000 deaths worldwide [1], with poor 
outcomes for advanced disease. Colorectal cancer develops from 
adenomatous polyps through the adenoma-carcinoma sequence [2,3]. 
Therefore detection of adenomatous polyps before they turn into cancer and 
polypectomy is important, and was shown to reduce colon cancer mortality. 
However, small hyperplastic polyps, accounting for one third of all polyps, 
have negligible malignant potential, especially if located in the left side of the 
colon.  
 
It has been traditionally felt that hyperplastic polyps cannot be separated 
clinically from adenomas or polyp cancers. For this reason all polyps are 
removed. However, polypectomy is associated with significant risks [4], 
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results in an immediate cost in processing the samples, increases the 
workload for pathologists, and increases the procedure time. However, It is 
becoming recognized that in-vivo characterization of lesions is possible, with 
the ASGE recently proposing standards for in-vivo assessments [5]. 
 
Image enhanced endoscopy in the  colon 
 
IEE can help in two ways: 
1) Improved lesion detection 
2) Improved lesion characterization 
 
There are many emerging technologies which can impact on both of these 
areas. These include high resolution (HD) colonoscopy and electronic imaging 
techniques including narrow band Imaging, FICE and i-scan, 
chromoendoscopy and novel devices including cap assisted colonoscopy and 
confocal endoscopy. This article will focus on chromoendoscopy and 
electronic imaging. To understand how these technologies can impact on 
lesion detection and characterization it is necessary to broadly understand 
how they work and the principles behind their use. 
 
Chromoendoscopy 
 
Chromoendoscopy involves application of a dye to the gastrointestinal tract. 
The techniques were pioneered in Japan where initial experience was in the 
use of the vital stain crystal violet to characterize colonic neoplasia. Crystal 
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violet irreversibly binds to cellular structures, highlighting surface patterns in 
great detail. It was with this dye that the first attempts were made at in-vivo 
histology prediction for colonic polyps. It cannot be used for lesion detection 
but is very effective for lesion characterization. However, it poses a number of 
problems. Vital stains are inconvenient to use. They have to be dripped onto 
the lesion surface and allowed to fix for several minutes, followed by washing 
prior to evaluation. This is time consuming and subjective. For this reason it is 
generally accepted that vital stains are not practical for daily use outside of a 
research setting. This led to a search for alternative dyes. 
 
Indigo carmine, generally used at a concentration of 0.2%, is a blue dye which 
does not bond to or react with human tissue. It simply sits on the surface of 
tissues, highlighting surface patterns. For this reason it is very safe. 
Furthermore, it is easier to use than crystal violet as the results are instant. As 
it does not bind to tissues, excess dye can be sucked away. Indigo carmine 
can be used for two purposes; to find polyps or to characterize neoplasia. 
Methylene blue is a similar blue dye. It differs however from indigo carmine in 
that it binds to tissues and therefore carries a theoretical risk of DNA damage. 
In practice it can be used in a very similar way to indigo carmine. 
 
Pan-chromoendoscopy for lesion detection in a surveillance population  
 
A Cochrane meta-analysis concluded that chromoendoscopy with indigo 
carmine enhances the detection of neoplastic polyps [6]. The review 
examined five randomized controlled trials, excluding polyposis or colitis 
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patients [7-11], representing 1059 patients. Chromoendoscopy significantly 
increased both the number of patients with at least one polyp detected (OR 
2.22) and the number of patients with at least one dysplastic lesion detected 
(OR 1.67). The predominant increase was in the number of diminutive 
adenomas detected. Four other randomized controlled trials were not included 
in the meta-analysis [12-15]. All but one of these studies [14] demonstrated 
improved lesion detection with indigo carmine. Methylene blue has shown 
similar results [102].  
 
Pan-chromoendoscopy for lesion detection in a high risk population 
 
Chromoendoscopy is potentially of benefit in hereditary syndromes by 
enhancing detection of subtle lesions. Indigo carmine chromoendoscopy has 
been studied in Familial adenomatous polyposis (FAP), attenuated FAP, and 
hereditary non-polyposis colorectal cancer (Lynch syndrome).  
 
Chromoendoscopy may help in making a diagnosis by revealing additional 
lesions required to meet a diagnostic criteria. A very small study has 
suggested that indigo carmine can help distinguish between attenuated FAP 
and classical FAP (>100 adenomas) [16]. Likewise, the diagnosis of 
hyperplastic polyposis syndrome is dependent on identification of a specific 
number of polyps, and chromoendoscopy may help in meeting the criteria 
[17].  
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Chromoendoscopy may be beneficial in the surveillance of polyp syndromes. 
back-to-back studies in Lynch syndrome suggest that polyp detection may be 
improved [18,19,20]. Dye-spray increases polyp detection in FAP surveillance 
[21]. Whether this is of any clinical value is unclear as most true FAP patients 
are treated with colectomy rather than surveillance. There are no studies 
published in hyperplastic polyposis syndrome or Peutz-Jeghers syndrome.  
 
Pan-chromoendoscopy in inflammatory bowel disease 
There is growing evidence that chromoendoscopy using indigo carmine is the 
optimum method for performing colitis surveillance. There are two randomized 
controlled trials and several large cohort studies comparing the technique to 
conventional mapping biopsies [22-30]. All of these trials have demonstrated 
improved neoplasia yields with pan-chromoendoscopy. A meta-analysis [31] 
examining these studies showed a 44% increase in detection of neoplasia 
with the majority of them being flat. The meta analysis also demonstrates a 
dramatic reduction in number of biopsies taken per patient from 40 with the 
conventional strategy to 11 with chromoendoscopy directed targeted biopsies. 
Studies with methylene blue have yielded similar results [103]. Recent ECCO 
guidelines recommends this as the strategy for ulcerative colitis surveillance. 
It should be noted that pan-chromoendoscopy is only of value when the 
patient is in remission. In the presence of active inflammation there is little to 
be gained through the application of dye spray, as ulceration, mucous and 
pus interferes with the assessment of surface patterns and makes such 
evaluations unreliable. 
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There is good evidence that pan-chromoendoscopy improves lesion detection 
in a routine surveillance population. However, pan-colonic dye spray, where 
indigo-carmine is applied to the entire colon using a spray catheter, has not 
become routine practice. There are a number of reasons for this. Dye 
spraying is time consuming messy and inconvenient. The colon has to be 
clean and free of debris and this remains a big challenge as bowel 
preparation in western settings is not perfect in all patients. Practically most 
western units would find the practice of pan-chromoendoscopy very 
challenging.  Furthermore, there is a lack of data to support whether this 
increase in lesion detection results in a long term reduction in cancer risk.  
 
Chromoendoscopy for lesion characterization 
 
There has been considerable work evaluating the use of chromoendoscopy in 
characterizing colonic lesions. The initial work with indigo carmine for in-vivo 
diagnosis was conducted in Japan by Kato et al. who retrospectively analysed 
4445 lesions using magnifying endoscopy with indigo carmine dye spray. All 
of the lesions were less than 5mm in size and assessed by evaluating surface 
patterns [32]. These patterns were originally described using vital stains 
(crystal violet) by Professor Kudo and have formed the cornerstone of most of 
the subsequent in-vivo diagnostic studies [33,34].  All of the lesions were 
assessed in-vivo, with the predicted diagnosis correlated with the 
histopathological diagnosis. The findings suggested that a sensitivity for 
adenoma of 98% and specificity of 52% could be achieved. The excellent 
sensitivity was achieved by compromising the specificity, resulting in a large 
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proportion of hyperplastic polyps being overcalled as adenomas. The data 
was dependent on 100x magnification with a magnifying endoscope.  
 
Further work was conducted in Japan [35] which investigated the differences 
between indigo carmine with and without magnification in the examination of 
small (<10mm) polyps. The results were encouraging, with a sensitivity for 
neoplasia of 93.1% and specificity of 76.1% being achieved. However, there 
was improvement with magnification. This suggested that in appropriately 
skilled hands, in-vivo diagnosis was possible without the need for 
magnification endoscopy or vital stains. There were further Japanese studies 
looking at magnification endoscopy with indigo carmine for in-vivo histology 
prediction which showed similar results [36-38]. See figure 1. 
 
 
There has been work from outside of Japan using magnifying 
chromoendoscopy with indigo carmine. Tischendorf et al in Germany 
conducted a prospective cohort study of neoplastic vs non neoplastic polyps 
using both narrow band imaging and indigo carmine with magnifying 
endoscopy. A sensitivity of 91.7% and specificity of 90% was achieved for 
indigo carmine using Kudo pit pattern analysis [39]. A large German study 
compared indigo carmine and the electronic imaging modality FICE in the 
assessment of polyps <10mm. The primary aims of this study were lesion 
detection. However a sub-group of 280 lesions were assessed using indigo 
carmine for histology prediction. A sensitivity for neoplasia of 87.6% and 
specificity of 62.0% was achieved [40]. High definition endoscopes were used 
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without optical magnification. There was a further German study by a different 
group examining indigo carmine with high resolution endoscopes. This study 
investigated 273 lesions <5mm, with a sensitivity of 94%, specificity of 64% 
and accuracy of 83% [41]. This study differed from the other studies described 
in that it only examined rectosigmoid polyps. Further similar  studies [42-46] 
are summarized in tables 1 and 2. 
It should be noted that methylene blue has also been studied for lesion 
characterization. The results have been excellent, and it is widely accepted 
that it can be used in the same way as indigo carmine [102]. 
 
A notable point observed in most of the published studies is the trade off 
between adenoma sensitivity and specificity. Many of the studies with the 
highest sensitivity have a low specificity, typically between 60-70%. Whilst this 
is the safest approach to in-vivo diagnosis, it is not ideal. The ultimate goal for 
diminuitive polyps <5mm in size would be to have the ability to confidently 
leave small hyperplastic polyps, reducing the risks posed by polypectomy. To 
achieve this, sensitivity and specificity both need to be very high.  
 
High definition colonoscopes are becoming an industry standard and it is 
important to know if they improve lesion characterization. A recent study 
published from the United Kingdom has suggested that diagnostic accuracy, 
sensitivity and specificity of assessment of colonic polyps <10mm in size was 
not affected by the resolution of the colonoscope used [47]. This was a single 
centre, single endoscopist study, but is the only study in this field. However, it 
is encouraging as standard resolution endoscopes are still in widespread use 
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and still being marketed and sold by most of the major endoscope 
manufacturers. HD endoscopes are more expensive and require updated 
processor and display screen which all come at extra cost and do improve the 
quality of image. However, clinicians can draw comfort from the above study 
that if they are using indigo carmine for in-vivo assessments then even 
standard definition endoscopes can produce comparable accuracy. 
 
Because of growing interest in the use of in-vivo diagnosis The American 
Society for gastrointestinal endoscopy (ASGE) has produced PIVI guidelines, 
setting standards a technique or technology needs to achieved to be used for 
in-vivo diagnosis [5]. This includes standards which need to be met for setting 
rescope intervals and for leaving small rectosigmoid hyperplastic polyps in-
vivo. Most of the indigo carmine studies are from the pre-PIVI era so do not 
report on PIVI standards but a recent study looked at the PIVI standards that 
can be achieved with indigo carmine [48]. This study used indigo carmine 
without optical magnification. The results were encouraging, with indigo 
carmine meeting both the requirements for rescope intervals and for leaving 
polyps in situ. It should be noted that the assessments were made after first 
assessing using the electronic imaging modality FICE. Indigo carmine did 
improve the negative predictive value of assessment, enough to meet the PIVI 
standard for leaving small left sided hyperplastic polyps in situ, although the 
change in accuracy, sensitivity and specificity was not statistically significant. 
See table 2. We can conclude from this study that indigo carmine when used 
after FICE will improve the negative predictive value to a standard that will let 
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us implement  ‘do not resect’ policy for diminuitive rectosigmoid polyps <5mm 
in size. 
There has been some work examining magnifying chromoendoscopy in the 
evaluation of sessile serrated polyps. A paper from Japan has suggested that, 
using a modified form of the Kudo pit pattern classification system, it is 
possible to identify sessile serrated adenomas with 83.7% sensitivity and 
85.7% specificity [101]. More work is needed in this field. 
Chromoendoscopy has been shown to be an effective tool in predicting depth 
of sub-mucosal invasion of early cancers in the colon [96-97], with accuracy 
between 71% and 91%. This requires magnifying endoscopes and highly 
skilled endoscopists. Furthermore, whilst some of the published work has 
used indigo carmine [97] the majority of assessments have used vital staining 
with crystal violet. The data has come from specialist centres in Japan and it 
is unclear whether such techniques could currently be used in a western 
setting. However, with the growth of EMR and ESD as the standard for 
removal of large benign colonic polyps it is possible that endoscopists will 
become more confident in their diagnostic abilities and that skills in this area 
will improve. 
 
Electronic imaging 
  
Some endoscopists have been critical of chromoendoscopy, claiming that it is 
a messy time consuming process. Furthermore, it physically colours the 
mucosa, requiring extensive washing if the endoscopist decides that he or she 
wants an unstained view. This has led to the development of push button 
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‘virtual chromoendoscopy’ techniques. These will be referred to collectively as 
‘electronic imaging’ for the purposes of this article. 
 
 
Narrow band imaging 
 
The first commercially available system came from Olympus, known as 
narrow band imaging (NBI). The concept of NBI is to improve visualization of 
mucosal vascular patterns. It is based on the principle of variable penetration 
of light depending on its wavelength. Red light penetrates deep into the 
submucosa but doesn’t help with surface pattern assessment. Blue and green 
light at a wavelength range of 415-540nm does not penetrate deep but 
enhances mucosal vessel patterns. Blue light displays superficial capillary 
networks whilst green light highlights subepithelial vessels. The result is a 
high contrast image which makes the interpretation of surface vascular 
patterns possible. NBI uses a physical filter to block red light and to narrow 
the bandwidth of the blue and green light, hence improving visualisation of 
surface patterns.  
 
Narrow band imaging for lesion detection 
 
Early studies suggested that there was some improvement in lesion detection 
using NBI [49-50]. This was not however repeated in later investigations 
[51,52,53]. The overall conclusions were that the gains seen in the preliminary 
studies were largely due to inexperienced endoscopists, still on a steep 
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section of the polyp detection learning curve. However, NBI did help improve 
polyp detection skills. When used by experts, who already had high adenoma 
detection rates, there was no gain [52] [54]. There has been a tandem 
endoscopy published which suggested that the adenoma miss rate may be 
lower in the proximal colon. Furthermore, a significantly higher number of 
small lesions <5mm were found using NBI compared to white light imaging in 
this study [94]. It is likely therefore that if there is any gain from NBI in lesion 
detection that it is small. 
 
Narrow band imaging in familial polyp syndromes 
There is limited evidence for use of NBI in any of the polyp syndromes. Due to 
profound differences between the syndromes it is difficult to consider them as 
a single group. The greatest evidence base is in hyperplastic polyposis, where 
a randomized controlled trial has been conducted [58]. This is perhaps 
unsurprising, as the key clinical aim in this condition is to identify adenomas 
amongst a sea of hyperplastic lesions, and there is evidence to suggest that 
electronic imaging is effective in differentiating hyperplastic from 
adenomatous polyps. There is some evidence in Lynch syndrome, but this is 
from small cohort studies and it is questionable whether these were 
adequately powered. Of the studies examining lynch syndrome it would 
appear there may be benefit from NBI, but there is a greater gain from 
chromoendoscopy.  
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There has been one cohort study examining NBI in the assessment of familial 
adenomatous polyposis (FAP). This involved analysis of images captured at 
live endoscopy [55]. In total thirteen patients with FAP were examined. 
Colonoscopic images were obtained using white light colonoscopy, 
autofluorescence imaging, NBI, and chromoendoscopy, with all images 
captured at equivalent angles and distances from the colorectal mucosa. 
Chromoendoscopy detected the greatest number of lesions at all sites. NBI 
depicted more lesions than white light. Autofluorescence imaging appeared 
superior in the rectum. The authors concluded that chromoendoscopy was the 
optimum imaging modality, and superior to white light colonoscopy, 
autofluorescence imaging, and NBI for detection of diminutive colorectal 
lesions in adenomatous polyposis. However, NBI was better than white light 
alone. 
There have been three published studies examining narrow band imaging in 
Lynch syndrome. A cohort study from the United Kingdom [56] examined 62 
patients from Lynch syndrome families, all diagnosed using the Amsterdam II 
or genetic criteria as part of a colonoscopic surveillance programme. All 
patients were examined twice from caecum to sigmoid-descending junction, 
first with high definition white light and then after a second pass with NBI in a 
back-to-back fashion. Initial adenoma detection in the proximal colon with 
white light was 17/62 (27%). 26/62 (42%) patients had at least one adenoma 
detected after NBI, with an absolute difference of 15% (95% CI 4-25%), 
p=0.004 versus white light alone. The authors commented that the proportion 
of flat adenomas detected in the NBI pass (9/21 (45%)) was higher than in the 
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white light pass (3/25 (12%)) p=0.03, suggesting that the principal gain was in 
the detection of flat adenomas in the proximal colon. 
A cohort study from Germany [57] examined 109 patients with HNPCC. In 47 
patients, standard colonoscopy was followed by chromoendoscopy with indigo 
carmine, and In 62 patients NBI was performed first followed by 
chromoendoscopy. 128 hyperplastic and 52 adenomatous lesions were 
detected in total.  0.5 lesions/patient were identified by standard colonoscopy 
and 1.5 lesions/patient by chromoendoscopy ( P < 0.001). 0.7 lesions/patient 
were detected by NBI. At least one adenoma was detected in 15 % of patients 
by both standard and NBI colonoscopy compared with 28 % of patients by 
chromoendoscopy. The authors concluded that chromoendoscopy detected 
significantly more adenomatous lesions than standard white light colonoscopy 
or NBI. 
 
There has been one randomized controlled trial [58] investigating NBI for the 
assessment of patients with hyperplastic polyposis syndrome. In total 22 
patients was identified.  Patients underwent tandem colonoscopy with high 
resolution white light and NBI, in randomized order with removal of all 
detected polyps. 209 polyps were detected (27 with normal histology, 116 
hyperplastic polyps, 42 sessile serrated adenomas, and 24 adenomas). 
Among patients assigned to white light first (n = 11) a total of 78 polyps was 
detected; subsequent NBI added 44 polyps. In patients examined with NBI 
first, 78 polyps were detected and subsequent white light added 9. Polyp miss 
rates of white light and NBI were 36% and 10% (OR 0.21; 0.09-0.45). Again, 
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in a similar fashion to the Lynch syndrome studies, flat polyp shape was 
independently associated with increased miss rate. The authors concluded 
that NBI significantly reduces polyp miss rates in hyperplastic polyposis 
patients. 
 
Narrow band imaging in inflammatory bowel disease 
Because of the success of chromoendoscopy in colitis surveillance, the 
question was asked whether narrow band imaging could achieve similar 
results. Three randomized controlled trials have attempted to answer this 
question [59-61], with all of these trials giving negative results. 
Two randomized controlled trials compared NBI to conventional 
chromoendoscopy. One of these trials [30] demonstrated a considerably 
higher miss rate with NBI compared to pan-chromoendoscopy (31.8% vs 
13.6%). The second trial [62] (which used methylene blue as the dye) showed 
comparable neoplasia detection rates. The position is therefore uncertain 
whether NBI can be used as an alternative to chromoendoscopy for colitis 
surveillance. However, it cannot be recommended as a suitable technique at 
present. 
 
 
Narrow band imaging for lesion characterization 
There have been numerous publications investigating the potential for In-vivo 
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histology prediction using NBI [63-70], with several classification systems 
validated specifically for use with NBI [99,100]. Similar results have been 
achieved to those seen with indigo carmine. Several publications have 
concentrated on non-magnifying endoscopes, perhaps most notable being the 
DISCARD study [68]. This was however a general study of in-vivo diagnosis, 
and the use of indigo carmine was allowed. Whilst the authors argued that this 
was only needed in a minority of cases, it is difficult to ascertain the efficacy of 
NBI on its own. Another study compared the accuracy of NBI with and without 
magnification [71]. This showed no statistically significant difference with or 
without magnification. However, the polyps were not assessed in-vivo. 
Pictures were taken and then reviewed after the procedure by two 
endoscopists. Therefore the results have to be interpreted with caution.  
 
NBI certainly appears very promising and provides accuracy close to 
histology. With the new validated classification systems it is ready for use in 
expert hands. However, acquiring competence may be challenging. Recent 
data has shown that, despite training, NBI was not that good in the hands of 
general endoscopists compared to the results obtained in expert centres, 
failing to meet the key standards laid down in the ASGE PIVI [74]. Similar 
issues have been raised in other, similar studies [93]. Whilst there are 
published studies suggesting that NBI can be taught relatively easily [101], 
this raises a concern about the widespread applicability of NBI / in-vivo 
diagnostic techniques outside of expert centres. This is an area needing 
further research. There has been a study published which has suggested that, 
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with appropriate training, high magnification NBI can increase the diagnostic 
skill of less experienced endoscopists to that of highly experienced 
endoscopists [95]. It may be that when learning to perform in-vivo 
assessments the greater clarity of patterns seen with magnification is highly 
beneficial, but that this becomes less important as experience increases. This 
should form the basis for future studies.    
Unlike the studies into indigo carmine dye spray, where Japanese research 
predominates, the work into NBI have come from a larger range of countries. 
This perhaps reflects the reluctance of western endoscopists to embrace dye 
spray. It should be noted however that the largest NBI study (1473 polyps) 
comes from Japan [69]. 
Of all vascular enhancement techniques the biggest evidence base exists for 
NBI. It is a tool where classification systems and assessment techniques have 
been developed specifically for use with it. Data has been produced from 
more than one centre, suggesting the techniques are reproducible in expert 
hands. Unfortunately all of the data has been produced using high definition 
equipment and it is necessary to assume, at present, that this is a prerequisite 
for in-vivo diagnosis. See table 3. Most studies have reported sensitivity 
between 82-95% and specificity of 75-90%. See figure 2 and table 3. 
There has been some work examining the use of narrow band imaging with 
optical magnification in examining depth of invasion of early colorectal 
cancers [98]. The early data was promising, suggesting that thick and 
severely irregular microvessels were diagnostic of sub-mucosal invasion. This 
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needs further evaluation in larger studies before introduction to mainstream 
practice. 
 
Flexible spectral imaging color enhancement (FICE) 
 
FICE is a post processor technology found on Fujifilm endoscopes. Unlike 
NBI, which utilizes a physical filter, FICE uses the charged coupled device 
(CCD) in the endoscope to capture spectral reflectance data. This is sent to a 
spectral estimation matrix processing circuit contained in the video processor. 
The reflectance spectra of corresponding pixels that make up the 
conventional image are mathematically estimated. From these spectra, a 
virtual image is reconstructed of a single wavelength. Three such single-
wavelength images can be selected and assigned to the red, green, and blue 
monitor inputs to display a composite colour enhanced multi band image in 
real time. This can be used like narrow band imaging to remove data from the 
red part of the waveband and narrow the green and blue spectra. However, 
the system is flexible. It has 10 pre set digital filter settings with the ability to 
program more.  
 
FICE is a technically more complex than NBI, and therefore potentially more 
flexible. This can prove off putting to clinicians who can find the multitude of 
settings confusing.  
 
FICE for lesion detection 
 
 23 
In a similar position to NBI, a multicenter randomized controlled trial 
investigating FICE for lesion detection in a surveillance population has 
concluded that FICE was no more effective than white light for lesion 
detection [40]. These results have been repeated in several further studies 
[75,76] with the same negative results. It would therefore appear that FICE 
has no role in improving polyp detection rates in the colon. There is no 
published data for FICE in high risk patient groups. 
 
 
 
FICE for lesion characterization 
 
Several studies into the in-vivo histology prediction of colonic polyps come 
from Germany. A prospective study of 150 polyps <2cm was compared to 
indigo carmine dye spray with low (50x) and high (100x) magnification using 
high resolution endoscopes (650,000 pixel CCD). The study was performed 
by taking static pictures of each polyp and reviewing them by 3 different 
readers after the procedure [77].  An accuracy of 83% and 90%, sensitivity of 
89.9% and 96.6% and specificity of 73.8% and 80.3% could be achieved with 
low and high magnification respectively. The results were essentially the 
same with Indigo carmine with no statistically significant difference between 
the two modalities. There are some important criticisms to note about this 
study. As it is based on static images it is unclear whether the results are 
directly transferrable to in-vivo diagnosis. Furthermore, as lesions over 1cm 
were allowed, it is unclear whether these results could be achieved with 
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smaller polyps which are arguably harder to assess. High definition (650,000 
pixel CCD) endoscopes were used and the results cannot be applied to 
standard definition equipment.  
 
The same team went on to conduct a further prospective randomized study 
with the primary aim to investigate the impact of FICE on adenoma detection 
rates (ADR) [40]. In this study lesion characterization was a secondary end 
point. It demonstrated that FICE was able to differentiate adenomas from 
hyperplastic polyps<10mm in size with a sensitivity of 93% and specificity of 
61.2%. Accuracy was 84.7%. This was comparable but not superior to that of 
indigo carmine, with no statistically significant difference between the two 
techniques (p=0.44). Specificity was sacrificed to achieve adequate 
sensitivity. Whilst safe, this approach limits the cost benefit position of in-vivo 
diagnosis. Lesions were assessed using Kudo’s pit patterns which are not 
validated for FICE. Furthermore, the primary end point of the study was not 
lesion differentiation, but lesion detection.  
 
There has been a Japanese study looking at histology prediction using FICE. 
This study was small, examining 107 polyps <5mm in size and utilizing optical 
magnification with high definition scopes. With high magnification (100x) a 
sensitivity of 93% specificity of 70% and accuracy of 87% was achieved. 
There was a small drop in accuracy with low (50x) magnification (87%) [37]. 
Again Kudo’s patterns were used for the assessments performed by 
Japanese experts.  
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Not all studies support these findings. There was a study in which five 
endoscopists assessed 144 pictures of 19 polyps to establish the diagnostic 
accuracy of WLI, FICE and indigo carmine in making a histology prediction for 
polyps <10mm in size. The results were disappointing, with a mean diagnostic 
accuracy for WLI of 57%, FICE without magnification of 58.9% and IC without 
zoom of 70.5% [78]. The methodology of this study could be criticized in many 
ways. The number of lesions was extremely small and it was picture based. 
Furthermore, It is unclear how experienced the endoscopists were in making 
an in-vivo diagnosis. They achieved similar (poor) results with indigo carmine 
which is out of keeping with previous studies. The Sano classification was 
used to assess the lesions with FICE. This is a system designed for Narrow 
band imaging [72]. Practically, the appearances are different with FICE to 
NBI, and the Sano classification has never been validated for use with FICE. 
See figure 3. 
 
A study from Brazil has described a surface pattern system which is not 
dissimilar to Kudo pit pattern classification but describing the vascular 
patterns seen with FICE [79]. The study enrolled 309 lesions ranging in size 
from 1-50mm, with 242 lesions <5mm in size. Again only high definition 
endoscopes were used and no attempt to examine without magnification was 
made. The authors commented that they felt optical magnification was 
essential for analysis of vascular patterns. An accuracy of 98.3% sensitivity of 
99.2% and specificity of 94.9% was achieved. The advantage of including 
larger lesions was that 22 cases of colorectal cancer could be examined, 
enabling a classification system to be validated. However, it does mean that 
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the very high sensitivity and specificity cannot be directly compared to the 
other studies looking at much smaller lesions. The authors did not attempt to 
analyze accuracy on the basis of lesion size.  
 
A further study has attempted to validate a more simple classification system 
for use with FICE, known as N.A.C.[92]. This classification system makes use 
of vascularity, vascular patterns and surface patterns. It is designed for use 
without optical magnification and makes use of both the white light and FICE 
enhanced images. The details of this system are shown in table 5.    
 
A recent study has examined FICE in a U.K. bowel cancer screening 
population, as has compared results to the ASGE PIVI standard [48]. The 
study suggested that FICE meets the PIVI standards for adopting a resect 
and discard strategy, but could not produce a negative predictive value 
sufficient for leaving recto-sigmoid hyperplastic polyps in situ. The same team 
went on to examine the impact of colonoscope resolution on diagnostic 
accuracy [80]. This study demonstrated an improvement in lesion 
characterization with a high resolution colonoscope, with greater accuracy for 
setting rescope intervals using ASGE and British Society of Gastroenterology 
(BSG) guidelines. It clearly demonstrated that if electronic imaging like FICE 
is to be used for in-vivo diagnosis then HD scopes are a must as they improve 
the accuracy to a level that all PIVI standards are comfortably met. This raises 
an important concept; whereas indigo carmine based assessments appear to 
be independent of colonoscope resolution, the same cannot be said for FICE. 
Whilst it is not clear whether the same issues apply to NBI or i-scan it should 
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be noted that all of the research on these systems has been performed using 
high resolution equipment. Therefore it is safest to assume that, until studies 
have been performed to prove or refute the position, that all electronic 
imaging assessments are best made using high resolution colonoscopes. See 
table 4. 
 
 
i-scan 
 
 The most recent introduction to vascular enhancement has come from 
Pentax. In some ways i-scan is a similar technology to FICE. It is a post 
processor reconstruction from spectral reflectance data. However, in addition 
to vascular enhancement it can also enhance surface patterns, increasing the 
contrast between edges without reducing the brightness of images. At present 
high definition 1.3 million pixel CCD endoscopes are available which have 
been marketed for use with this system. These are not equipped with optical 
magnification.  
 
An early study using i-scan has suggested that increased lesion detection can 
be achieved using the surface pattern enhancement setting [81]. This is in 
stark contrast to results seen with NBI and FICE. The argument has been 
made that the surface pattern enhancement features are fundamentally 
different from the vascular enhancement of NBI and FICE, which explains the 
difference. However, these results were not replicated in a subsequent trial 
[82] and this is an area requiring further research.  
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There has been a study examining i-scan in hereditary polyp syndromes (83). 
This study used the tone enhancement (TE) capacity of i-scan in Lynch 
syndrome. In total 49 patients underwent back-to-back colonoscopy with two 
imaging modalities, randomized into 2 groups. Group 1 (25 patients) 
underwent High definition white light (HDWL) first followed by i-scan, group 2 
(24 patients) i-scan first followed by High definition white light. The lesion 
detection rate was 0.73 for i-scan and 0.36 for HDWL (p=0.095). In group 1, 
14 lesions were detected with HDWL first and 15 with subsequent i-scan. In 
group 2, 21 lesions were detected with i-scan first and 4 with subsequent 
HDWL. The miss rate for endoscopic lesions was 52% and 16% respectively 
and was significantly different in favor of i-scan (p<0.01).  The authors 
concluded that In patients with Lynch syndrome the miss rate for polyps is 
significantly reduced during colonoscopy performed with i-scan in comparison 
to high definition white light. 
i-scan for lesion characterization 
 
The previously described study examining i-scan for lesion detection [81] also 
examined the role of i-scan in lesion characterization. in-vivo histology 
prediction was made on 145 polyps <10mm with a sensitivity of 98%, 
specificity of 100% and accuracy of 98.6%. Kudo pit patterns were used for 
assessment. The most recent study from the United Kingdom called the Hi-
scope trial suggested similar results for i-scan [85].  However, this study was 
unique in comparing the high resolution white light diagnosis to the i-scan 
diagnosis. The authors found no significant difference in accuracy rates 
between high definition white light and i-scan. This is in sharp contrast with 
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other similar studies comparing white light to enhanced imaging such as NBI 
or FICE. Of note the white light accuracy was excellent, with much better 
results achieved than those seen in previous studies where white light was 
used for histology prediction [48]. It should be noted that Pentax 
colonoscopes have a higher resolution than the other endoscope 
manufacturers. The authors argued that such high accuracy with high 
definition white light could be due to high levels of expertise and high 
definition colonoscopes. It is quite likely that in the past publications and 
investigations could have been biased in favour of enhanced technologies like 
NBI, etc. and has undervalued the role of high definition white light. It is also 
possible that the endoscopists involved in the Hi-scope trial have improved 
their in-vivo diagnostic skills over the years with the aid of enhanced imaging 
techniques and chromoendoscopy and now they can make very accurate 
diagnoses even with high definition white light. These results need to be 
replicated by other investigators. See figure 4. 
 
 
The cost effectiveness of in-vivo diagnosis 
 
An important aspect of all in-vivo diagnostic techniques is what value they add 
to clinical assessment. We feel such assessments have several functions. In 
larger polyps it is essential to correctly identify potential areas of invasive 
cancer, as it can affect whether to undertake endoscopic resection or refer for 
surgery. Assessment can also help target the correct area for biopsy to 
achieve accurate histological confirmation. In contrast, in small polyps the key 
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is distinguishing neoplastic from non-neoplastic polyps. This can allow the 
endoscopist to practice strategies like ‘resect and discard’ and ‘do not resect’ 
small hyperplastic polyps in the rectosigmoid. This could reduce complications 
associated with unnecessary polypectomy and result in a reduction in costs 
and burden to histopathology departments. Finally, it can enable surveillance 
intervals to be set accurately at the time of endoscopy.  
 
The cost effectiveness of in-vivo diagnosis has been examined in 5 papers. 
The first study from the United Kingdom [68] introduced the concept of resect 
and discard and made cost calculations, suggesting savings of $169 per 
patient undergoing colonoscopy.  Rescope intervals could be set accurately 
98% of the time using BSG guidelines. 
 
A study based upon a Markov model examined potential cost and clinical 
implications of applying resect and discard policy to the United States of 
America screening population [87]. The authors concluded that an annual 
undiscounted saving of $33 million /year could be made ($25/person) with a 
negligible impact on rescope intervals or screening efficacy. A further cross 
sectional analysis of American surveillance colonoscopy [88] examined data 
from a single-institution tertiary referral centre. A Decision analysis model 
examined the effects on surveillance intervals, costs and clinical outcomes of 
two strategies for polyp assessment; conventional histological examination of 
all polyps and in-vivo diagnosis of diminuitive lesions <5mm in size. It 
calculated up-front cost savings which could be achieved from forgoing 
conventional histological assessment and assessed the frequency of incorrect 
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surveillance intervals based on errors in both histological and endoscopic in-
vivo assessment. It also assessed the number needed to cause harm from 
adoption of an in-vivo assessment strategy, based on published sensitivity 
and specificity data of endoscopic  assessments using NBI, FICE and i-scan. 
The model predicted that pathology set surveillance intervals incorrectly in 
1.9% of cases, and that this would increase to 11.8% of cases if an in-vivo 
assessment was used instead. The annual up-front cost savings from in-vivo 
diagnosis would exceed a billion dollars. Less than 10% of this would be 
offset by downstream costs and consequences of forgoing pathology. The 
number needed to harm would be over 11,000. This study includes data on all 
of the main diagnostic systems but did not include any papers where 
chromoendoscopy with indigo carmine was used, although such papers were 
referenced. Given that most studies have suggested at least equal efficacy 
from chromoendoscopy this paper would effectively be relevant to such 
models for in-vivo diagnosis as well.   
 
The fourth study came from the United Kingdom which looked at in-vivo 
diagnosis in the UK Bowel Cancer Screening Programme (BCSP) [48]. This 
single centre study included polyps less than 10mm in size. Calculations for 
cost effectiveness were based on histology costs alone. It suggested a total 
saving of £678,253 (€762,767) could be made per annum within the 
programme (which was at its infancy), or £55 (€62) per patient undergoing 
colonoscopy, with a negligible impact on rescope intervals. The UK BCSP 
uses Faecal occult blood tests prior to colonoscopy, hence polyp detection 
rates in this population were high, making the potential savings higher than in 
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the US screening population. The proposed cost savings from this should, if 
applied to the current screening programme, result in a several fold higher 
cost savings than initially proposed due to the increase in the number of 
patients undergoing colonoscopy in the porgramme. The most recent work on 
cost effectiveness is an American retrospective multicentre study [89]. The 
authors suggest an even larger saving of $309 per patient screened could be 
made, with assessments meeting the standards set in the ASGE PIVI.  
 
A flaw with all of the cost effectiveness studies is the assumption that 
endoscopists reach the required level of expertise quickly and easily. None of 
the studies take into account the cost of training to achieve this, which may be 
significant. This has not been studied and should form the focus for future 
work. 
 
Summary 
 
There is a growing body of literature demonstrating what can and cannot be 
achieved by image enhanced endoscopy. It would appear that the greatest 
role lies in lesion characterization, where all of the available techniques have 
demonstrated effectiveness in expert hands. It is an essential skill for all 
endoscopists involved in resection of large and challenging polyps but is 
becoming increasingly recognized as an effective technique for the 
assessment of small polyps. Such techniques may one day be able to replace 
conventional histology in selected patient groups. The role of lesion detection 
is more controversial. Whilst indigo carmine is effective, challenges in its 
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usage have prevented its widespread adoption. Electronic imaging does not 
seem adequate for this purpose, although the picture is less clear with i-scan 
where more work is needed. The role in high risk patient groups is less clear, 
with most of the studies small with varying objectives. Chromoendoscopy is 
the technique of choice for surveillance of inflammatory bowel disease. Data 
is lacking with electronic imaging for this purpose and large studies will be 
required to answer this question. What has become very evident is that 
advanced imaging techniques have challenged the way we detect and 
evaluate polyps. Lesion identification has become a priority, and the 
endoscopist is no longer perceived as simply a tissue retrieval technician but 
an integral part of the diagnostic process. We feel that literature from expert 
centres has proven the potential of these imaging technique but generalizing 
of these techniques outside the expert centres still remains to be proven. This 
is an area for future research and we remain optimistic. 
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Figure 1: Adenomatous polyp after indigo carmine dye spray 
Figure 2: Adenomatous polyp viewed with Narrow band imaging 
Figure 3: An adenomatous polyp viewed with FICE on setting 4 
Figure 4: Adenomatous polyp viewed with i-scan setting 3 
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Author Country Journal Year Size Dye No polyps Sensitivity Specificity Accuracy 
Togashi 
(13) 
Japan Dis Colon Rectum 1999 All size Ingigo 
carmine 
923 92% 73.3% 88.4% 
Kato (32) Japan Endoscopy 2001 <5mm 
excluded 
No max 
size 
Indigo 
carmine 
4445 94% 75% NR 
Tung (36) Taiwan Am J Gastro 2002 <10mm Indigo 
carmine 
175 93.8.% 64.6% 80.1% 
Fu (35) Japan Endoscopy 2003 <10mm Indigo 
carmine 
206 96.3% 93.5% 95.6% 
Konishi 
(45) 
Japan Gastrointestinal 
endoscopy 
2003 <10mm Indigo 
carmine 
405 97% 100% 93% 
 
Su (90) Taiwan Dig Dis Sci 2004 <10mm Indigo 
carmine 
270 95.1% 86.8% 91.9% 
Hurlstone 
(44) 
UK Gut 2004 Any size Indigo 
carmine 
and crystal 
violet 
1008 98% 92% NR 
Palma 
(43) 
Italy World J 
Gastroenterology 
 
2006 <5mm Indigo 
carmine 
240 97.5% 94.3% 95.4% 
Sonwalker 
(46) 
UK with 
Japan 
Endoscopy 
 
2007 Any size Indigo 
carmine 
709 
(513<10mm) 
91% 87% 90% 
Tiscendorf 
(39) 
Germany Endoscopy 2007 Any size Indigo 
carmine 
200 (100 
with IC) 
91.7% 90% NR 
Pohl (77) Germany American Journal of 
Gastroenterolog 
2008 <20mm Indigo 
carmine 
(picture) 
150 95.5% 73.8% 87.7% 
Togashi 
(37) 
Japan Gastrointestinal 
endoscopy 
2009 <5mm Indigo 
carmine 
107 90% 74% 86% 
Table 1: Summary of publications stating accuracy, sensitivity and specificity of chromoendoscopy 
with optical magnification (NR=not reported). 
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Author Country Journal Year Size No 
polyps 
Sensitivity Specificity Accuracy 
Eisem 
(42) 
USA Gastrointestinal 
Endoscopy 
2002 <10mm 520 82% 82% 82% 
Fu (35) Japan Endoscopy 2003 <10mm 206 96.3% 93.5% 95.6% 
Konishi 
(45) 
Japan Gastrointestinal 
endoscopy 
2003 <10mm 405 97% 
86% 
100% 
61% 
68% 
93% 
Apel (41) Germany Gastrointestinal 
endoscopy 
2006 <5mm 273 94% 64% 83% 
Pohl (40) Germany Gut 2009 <10mm 280 87.6% 62.0% NR 
Longcroft-
Wheaton 
(47) 
UK UEG journal 2013 <10mm 237 91% SD 
96% HD 
87% SD 
84% HD 
89% SD 
92% HD 
Longcroft-
Wjeaton 
(48) 
UK Eur J 
Gastrohep 
2011 <10mm 232 94% 84% 91% 
Table 2: Summary of publications stating accuracy, sensitivity and specificity of chromoendoscopy 
with indigo carmine on polyps<10mm without optical magnification (NR=not reported) 
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Author Countr
y 
Journa
l 
Year Modality Endoscop
e 
No Sensitivity Specificity Accuracy 
Machid
a  (54) 
Japan Endosc 2004 NBI Zoom 43 100% 75% NR 
Chiu 
(65) 
Taiwan Gut 2007 NBI 
(pictures) 
Zoom 
non zoom 
180 82-86% 
87-95% 
59-83% 
71-88% 
81-82% 
87-90% 
Rastog
i (50) 
USA GIE 2008 NBI HD [1] 123 86-92% 86-92% NR 
Rogart 
(66) 
USA GIE 2008 NBI Zoom 265 80% 81% 80% 
East 
(56) 
UK Endosc 2008 NBI HD+zoom 116 88% 91% 89.6% 
Ragsto
gi (67) 
USA Am J 
Gastro 
2009 NBI  HD without 
magnificati
on 
236 
all 
size 
96% NR 93% 
Ignjato
vic (68) 
UK Lancet 
Onc 
2009 NBI with 
IC 
HD 278 94% 89% 93% 
Sano 
(72) 
Japan GIE 2009 NBI HD+zoom 150 96.4% 92.3% 95.3% 
Wada 
(70) 
Japan GIE 2009 NBI 
(pictures) 
HD+zoom 617 90.9% 97.1% NR 
Henry 
(73) 
USA GIE 2010 NBI 
(retrospe
ctive 
pictures) 
Uncertain 126 93% 88% 91% 
Wada 
(69) 
Japan Dig 
Endosc 
2010 NBI Uncertain 147
3 
88.9% 98.9% 98.2% 
Tische
ndorf 
(71) 
Germa
ny 
Endosc 2010 NBI 
(pictures) 
HD with 
and without 
zoom 
200 87.9% 
92.1% 
90.5% 
89.2% 
NR 
Van 
Den 
Broek 
(91) 
The 
Netherl
ands 
Clinical 
Gastro 
and 
Hepat 
2009 Trimodal 
imaging 
HD + zoom 208 99% 35% 63% 
Table 3: Accuracy, sensitivity and specificity for narrow band imaging (NBI), auto fluorescence 
imaging (AFI) and trimodal imaging. IC= indigo carmine, HD= high definition NR= not reported 
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Author Country Journal Year Modality Endoscope No Sensitivity Specificity Accuracy 
Pohl 
(77) 
German Am J 
Gastro 
2008 FICE 
(picture) 
HD low and 
high 
magnificatio
n<20mm 
150 89.9% 
 
96.6% 
73.8% 
 
80.3% 
83% 
 
90% 
Pohl 
(12) 
German Gut 2009 FICE 
(subgroup 
analysis) 
HD non 
zoom<10m
m 
321 
<10
mm 
93% 61.2% 84.7% 
Togashi 
(37) 
Japan GIE 2009 FICE HD low 
(50x) and 
high  (100x) 
magnificatio
n<5mm  
107 93% 70% 87% 
Teixiera 
(79) 
Brazil GIE 2009 FICE HD with 
zoom polyps 
up to 50mm 
309  99.2% 94.9% 98.3% 
Parra-
Blanco 
(78) 
Spain World 
Journal  
Gastro 
2009 FICE 
(picture) 
HD with and 
without 
zoom<5mm 
(picture) 
19  NR NR 58.9% 
 
70.5% 
Longcro
ft-
Wheato
n (48) 
UK Eur J. 
Gastro 
2011 FICE Polyps 
<10mm 
resolution 
not stated 
232 88% 82% 
 
86% 
Longcro
ft-
Wheato
n (80) 
UK Endosco
py 
2012 FICE HD and SD 
assessment
s 
293 SD 83% 
HD 93% 
SD 82% 
HD81% 
SD 83% 
HD 89% 
Hoffma
n (81) 
German
y 
endosco
py 
2010 i-scan HD<10mm 145 98% 100% 98.6% 
Hoffma
n (84) 
German
y 
Dig Liver 
Dis 
2010 i-scan HD<5mm 
rectosigmoi
d 
335 100% 100% 100% 
Basford 
P (85) 
UK GIE 2013 I scan HD<10mm 209 97% 90.7% 94.7% 
Table 4: Summary of papers published using FICE and i-scan for in-vivo diagnosis. NR=not reported 
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  Hyperplastic Adenomas Cancers 
White light vascularity Pale Dark Dark 
FICE vascularity Pale Dark Very dark 
FICE vascular pattern Absent vascular 
pattern or faint 
vessels not 
following crypts 
 
Regular pericryptal 
pattern  
Dense irregular pattern 
FICE surface pattern No surface pattern 
or large non 
compact crypt 
pattern 
 
Small compact regular 
pattern 
Disorganised irregular 
pattern 
Table 5: N.A.C. classification system 
 
